Dacogen 50 mg powder for concentrate for solution for infusion. clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
Precision therapy versus standard therapy in Acute Myeloid Leukaemia and Myelodysplastic syndrome in elderly (PALM) – a phase II randomized clinical trial
This study looks at new, personalised treatments for older people with certain blood cancers like Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS). It compares these 'precision' treatments with standard care to see which works best and offers the best value for money in improving quality of life.
For: Chronic myelomonocyte leukemia · Myelodysplastic syndrome · Acute myeloid leukemiaNorway - Ongoing, recruitingTherapeutic exploratory (Phase II)
Phase II study on Venetoclax (VEN) plus Decitabine (DEC) (VEN-DEC) for elderly (≥60 <75years) patients with newly diagnosed Acute Myeloid Leukemia (AML) elegible for allogeneic Stem Cell Transplantation (allo-SCT)
This study looks at a new treatment called Venetoclax plus Decitabine for older patients (60-74 years) with a type of blood cancer called Acute Myeloid Leukemia (AML). It aims to see if this treatment helps them get a stem cell transplant, which can be a cure for AML.
For: Acute Myeloid Leukemia (AML)Italy - Ongoing, recruitingTherapeutic exploratory (Phase II)
Phase II Combination Study of NMS-01940153E and Atezolizumab with or without a prior priming with low dose decitabine for the Treatment of Adult Patients with Unresectable Hepatocellular Carcinoma (HCC) Previously Treated with Immune Checkpoint Inhibitors
This study is testing a new combination of medicines for adults with liver cancer that has spread too widely to be removed by surgery. It's for people whose cancer has already been treated with a type of immunotherapy. Researchers want to see how well these new combinations work.
For: Unresectable Hepatocellular Carcinoma (HCC)Spain · Italy